JP2001510465A5 - - Google Patents

Download PDF

Info

Publication number
JP2001510465A5
JP2001510465A5 JP1998527767A JP52776798A JP2001510465A5 JP 2001510465 A5 JP2001510465 A5 JP 2001510465A5 JP 1998527767 A JP1998527767 A JP 1998527767A JP 52776798 A JP52776798 A JP 52776798A JP 2001510465 A5 JP2001510465 A5 JP 2001510465A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP1998527767A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001510465A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1997/022298 external-priority patent/WO1998027072A1/en
Publication of JP2001510465A publication Critical patent/JP2001510465A/ja
Publication of JP2001510465A5 publication Critical patent/JP2001510465A5/ja
Ceased legal-status Critical Current

Links

JP52776798A 1996-12-17 1997-12-12 2,4,6,8,10,12−ヘキサニトロ−2,4,6,8,10,12−ヘキサアザテトラシクロ[5.5.0.0▲上5.9▼0▲上3.11▼]−ドデカンを結晶化させる塩析法 Ceased JP2001510465A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3339296P 1996-12-17 1996-12-17
US60/033,392 1996-12-17
PCT/US1997/022298 WO1998027072A1 (en) 1996-12-17 1997-12-12 Salting-out process of crystallizing 2,4,6,8,10,12-hexanitro-2,4,6,8,10,12-hexaazatetracyclo[5.5.0.0?5,903,11¿]-dodecane

Publications (2)

Publication Number Publication Date
JP2001510465A JP2001510465A (ja) 2001-07-31
JP2001510465A5 true JP2001510465A5 (enExample) 2005-02-10

Family

ID=21870159

Family Applications (1)

Application Number Title Priority Date Filing Date
JP52776798A Ceased JP2001510465A (ja) 1996-12-17 1997-12-12 2,4,6,8,10,12−ヘキサニトロ−2,4,6,8,10,12−ヘキサアザテトラシクロ[5.5.0.0▲上5.9▼0▲上3.11▼]−ドデカンを結晶化させる塩析法

Country Status (10)

Country Link
US (1) US5874574A (enExample)
EP (1) EP0946527B1 (enExample)
JP (1) JP2001510465A (enExample)
KR (1) KR20000069513A (enExample)
AU (1) AU5374398A (enExample)
CA (1) CA2275317A1 (enExample)
DE (1) DE69727963T2 (enExample)
IL (1) IL130308A0 (enExample)
NO (1) NO313698B1 (enExample)
WO (1) WO1998027072A1 (enExample)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6217799B1 (en) * 1997-10-07 2001-04-17 Cordant Technologies Inc. Method for making high performance explosive formulations containing CL-20
FR2770216B1 (fr) * 1997-10-29 1999-12-03 Poudres & Explosifs Ste Nale Procede d'obtention de la forme polymorphe epsilon de l'hexanitrohexaazaisowurtzitane
US6214988B1 (en) 1999-01-03 2001-04-10 Schlumberger Technology Corporation Process for making an HMX product
WO2000052011A2 (en) 1999-02-16 2000-09-08 Alliant Techsystems Inc. Process for making 2,4,6, 8,10,12- hexanitro- 2,4,6,8,10, 12- hexa azatetracyclo [5.5.0. 0?5,9.03,11¿] -dodecane
US6194571B1 (en) 1999-05-26 2001-02-27 Schlumberger Technology Corporation HMX compositions and processes for their preparation
US6201117B1 (en) 1999-05-26 2001-03-13 Schlumberger Technology Corporation Process for making a 1,3,5,7-tetraalkanoyl-1,3,5,7-tetraazacyclooctane
US6428724B1 (en) 1999-05-26 2002-08-06 Schlumberger Technology Corporation Granulation process
US6265573B1 (en) 1999-05-26 2001-07-24 Schlumberger Technology Corporation Purification process
US6841016B1 (en) * 2000-03-02 2005-01-11 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno Process for the production of crystalline energetic materials
US6350871B1 (en) 2000-03-31 2002-02-26 Alliant Techsystems Inc. Crystallization of 2,4,6,8,10,12-hexanitro-2,4,6,8,10,12-hexaazatetracyclo[5.5.0.05,903,11]-dodecane
US7288648B2 (en) 2000-10-06 2007-10-30 Alliant Techsystems Inc. High temperature crystallization of 2,4,6,8,10,12-hexanitro-2,4,6,8,10,12-hexaazatetracyclo[5.5.0.05,903,11]-dodecane
US20050048126A1 (en) * 2000-12-22 2005-03-03 Barrett Rabinow Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug
US20030096013A1 (en) * 2000-12-22 2003-05-22 Jane Werling Preparation of submicron sized particles with polymorph control
US6884436B2 (en) * 2000-12-22 2005-04-26 Baxter International Inc. Method for preparing submicron particle suspensions
AU2002303087A1 (en) * 2001-02-09 2002-10-08 Alliant Techsystems Inc. Reformulation of composition c-4 explosive
IL160156A0 (en) 2001-08-01 2004-07-25 Alliant Techsystems Inc Low sensitivity explosive compositions and method for making explosive compositions
CN1558755A (zh) * 2001-09-26 2004-12-29 ���ع��ʹ�˾ 通过分散和除去溶剂或液相制备亚微米大小的纳米颗粒
US7112340B2 (en) * 2001-10-19 2006-09-26 Baxter International Inc. Compositions of and method for preparing stable particles in a frozen aqueous matrix
US6992185B2 (en) 2002-01-09 2006-01-31 Alliant Techsystems Inc. Crystallization of 2,4,6,8,10,12-hexanitro-2,4,6,8,10,12-hexaazatetracyclo[5.5.0.05,903,11]-dodecane
MX2007015183A (es) * 2005-06-14 2008-02-19 Baxter Int Formulaciones farmaceuticas para minimizar las interacciones farmaco-farmaco.
EP1954245A2 (en) * 2005-11-15 2008-08-13 Baxter International Inc. Compositions of lipoxygenase inhibitors
WO2008080047A2 (en) * 2006-12-23 2008-07-03 Baxter International Inc. Magnetic separation of fine particles from compositions
US8426467B2 (en) * 2007-05-22 2013-04-23 Baxter International Inc. Colored esmolol concentrate
US8722736B2 (en) * 2007-05-22 2014-05-13 Baxter International Inc. Multi-dose concentrate esmolol with benzyl alcohol
US20080293814A1 (en) * 2007-05-22 2008-11-27 Deepak Tiwari Concentrate esmolol
FR2950623B1 (fr) * 2009-09-29 2011-10-21 Snpe Materiaux Energetiques Suspension de cristaux d'hexanitrohexaazaisowurtzitane, obtention desdites suspensions et fabrication d'objets pyrotechniques.
RU2447075C9 (ru) * 2011-01-11 2012-11-20 Открытое акционерное общество "Федеральный научно-производственный центр "Алтай" Способ получения гамма-полиморфной модификации 2,4,6,8,10,12-гексанитро-2,4,6,8,10,12-гексаазатетрацикло[5,5,0,03,11,05,9]додекана
CZ303686B6 (cs) 2011-09-29 2013-03-06 Univerzita Pardubice Zpusob prípravy epsilon-2,4,6,8,10,12-hexanitro-2,4,6,8,10,12-hexaazaisowurtzitanu se snízenou citlivostí k nárazu
CN105418619B (zh) * 2015-12-29 2017-12-12 山西北化关铝化工有限公司 一种特质六硝基六氮杂异伍兹烷的制备方法
CN105693734B (zh) * 2016-03-15 2018-11-09 北京理工大学 一种特质ε-HNIW晶体及其制备方法
US10626061B2 (en) * 2017-08-03 2020-04-21 National Technology & Engineering Solutions Of Sandia, Llc Synthesis of energetic material particles with controlled morphology
CN119425143A (zh) * 2024-10-11 2025-02-14 西安近代化学研究所 一种基于微流控技术的ε-HNIW粒度调控方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE451718B (sv) * 1984-04-04 1987-10-26 Nobel Kemi Ab Sett att omkristallisera sprengemnena oktogen och hexogen
DE3617408C1 (de) * 1986-05-23 1987-06-11 Dynamit Nobel Ag Verfahren zur Herstellung von feinkoernigem beta-Oktogen
US4785094A (en) * 1986-09-26 1988-11-15 Morton Thiokol, Inc. Crystallization of beta HMX
US5132409A (en) * 1987-01-12 1992-07-21 Bracco Industria Chimica S.P.A. Macrocyclic chelating agents and chelates thereof
US5693794A (en) * 1988-09-30 1997-12-02 The United States Of America As Represented By The Secretary Of The Navy Caged polynitramine compound
US5707634A (en) * 1988-10-05 1998-01-13 Pharmacia & Upjohn Company Finely divided solid crystalline powders via precipitation into an anti-solvent
WO1990003782A2 (en) * 1988-10-05 1990-04-19 The Upjohn Company Finely divided solid crystalline powders via precipitation into an anti-solvent
DE4200743C2 (de) * 1991-09-18 1994-04-07 Wasagchemie Sythen Gmbh Verfahren und Vorrichtung zur Verringerung der Korngröße von kristallinem Explosivstoff
US5124493A (en) * 1991-10-15 1992-06-23 The United States Of America As Represented By The Secretary Of The Army Process of producing XMX in 100% yield and purity
US5268469A (en) * 1991-10-15 1993-12-07 The United States Of America As Represented By The Secretary Of The Army Process of making impact insensitive Alpha-HMX
US5723604A (en) * 1995-06-22 1998-03-03 Thiokol Corporation Synthesis of 2,4,6,8,10,12-hexabenzyl-2,4,6,8,10,12-hexaazatetracyclo 5.5.0.05,9.03,11!dodecane
US5739325A (en) * 1995-12-07 1998-04-14 Thiokol Corporation Hydrogenolysis of 2,4,6,8,10,12-Hexabenzyl-2,4,6,8,10,12-Hexaazatetracyclo 5.5.0.05,9.03,11 !dodecane

Similar Documents

Publication Publication Date Title
JP2000502280A5 (enExample)
JP2000501771A5 (enExample)
JP2000504884A5 (enExample)
JP2000501599A5 (enExample)
JP2000501018A5 (enExample)
JP2000500076A5 (enExample)
JP2000501324A5 (enExample)
JP2000500055A5 (enExample)
JP2000502472A5 (enExample)
JP2000501825A5 (enExample)
JP2000501338A5 (enExample)
JP2000500874A5 (enExample)
JP2000502425A5 (enExample)
JP2000502485A5 (enExample)
JP2000502568A5 (enExample)
JP2000501774A5 (enExample)
JP2000500912A5 (enExample)
JP2000502570A5 (enExample)
JP2000501876A5 (enExample)
JP2000501744A5 (enExample)
JP2000501229A5 (enExample)
JP2000502316A5 (enExample)
JP2000500857A5 (enExample)
JP2000502714A5 (enExample)
JP2000501569A5 (enExample)